The ASX All Ordinaries index is having a strong session on Tuesday.
In morning trade, the widely followed index is up 1.1% to 8,786.2 points. This has been driven by news of a ceasefire between Israel and Iran.
One ASX All Ords stock that is delivering an even stronger gain for its shareholders is Cogstate Ltd (ASX: CGS).
At the time of writing, the neuroscience technology company's shares are up 15% to a 52-week high of $1.55.
Image source: Getty Images
What is Cogstate?
Before we tackle why its shares are rising strongly today, let's just look at what Cogstate actually does.
The ASX All Ords stock describes itself as a neuroscience technology company optimising brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare.
Its technologies provide rapid, reliable and highly sensitive computerised cognitive tests across a growing list of domains and support electronic clinical outcome assessment (eCOA) solutions to replace costly and error-prone paper assessments with real-time data capture.
In addition, it notes that its clinical trials solutions include quality assurance services for study endpoints that combine innovative operational approaches, advanced analytics and scientific consulting.
Why is this ASX All Ords stock jumping?
Investors have been fighting to get hold of the company's shares today this morning after it released an update on its guidance for FY 2025.
According to the release, the second half of FY 2025 has been stronger than expected. As a result, the company expects its revenue to be in the range of US$28.1 million to US$30.1 million in revenue and US$6.8 million to US$8.8 million in profit before tax.
This reflects a strong performance across the company's core business segments.
In light of the above, the ASX All Ords stock now expects its revenue to be between US$52 million and US$54 million in FY 2025. This represents a 20% to 24% increase over the previous year.
Profit before tax is forecasted to range from US$12 million to US$14 million, a significant improvement of 69% to 97% compared to FY 2024.
Following today's gain, this ASX All Ords stock is now up a sizeable 37% since this time last year. To put that into context, a $10,000 investment this time last year would now have turned into a sizeable $13,700.
